Pharma.Aero will host a special industry briefing webinar on 11 March 2026 (14:00 CET) to analyse the geopolitical crisis in the Gulf and its potential impact on global life science supply chains.
Recent geopolitical developments in the Gulf region are creating uncertainty across key international transport corridors that support the movement of pharmaceuticals and medical technologies worldwide. For pharmaceutical supply chains, where reliability, regulatory compliance, and product integrity are critical, understanding potential disruptions and operational implications is essential.
In response to the evolving situation, Pharma.Aero is convening industry experts, academic specialists, and life science manufacturers to provide timely insights and discuss the potential consequences for global pharma logistics networks.
Expert perspectives on geopolitical risk and supply chain resilience
The session will begin with an update on the current geopolitical context and its implications for the global pharmaceutical logistics ecosystem, presented by Frank Van Gelder, Secretary General of Pharma.Aero.
Participants will then hear from Prof. Dr. Wouter Dewulf, Professor at the University of Antwerp, who will examine the direct impact of geopolitical developments on global life science supply chains, as well as the mid- to long-term outlook for international logistics corridors and transport networks.
As geopolitical tensions increasingly affect global trade routes, the ability of pharmaceutical supply chains to remain resilient and adaptive is becoming a central topic for the industry.
Operational insights from life science manufacturers
The webinar will also feature real-world operational perspectives from members of Pharma.Aero’s Life Science Manufacturers Advisory Platform (LMAP).
Representatives from leading pharmaceutical and biotechnology companies will share insights on how organisations are currently assessing geopolitical risks and adapting supply chain strategies.
Industry contributors include Batavia Biosciences, Eli Lilly and Company, Integra LifeSciences and MSD. Their perspectives will help illustrate how life science companies are managing supply chain continuity while maintaining strict quality and compliance requirements in an increasingly complex geopolitical environment.
The briefing will conclude with an interactive Q&A session, allowing participants to exchange perspectives with speakers and peers from across the global pharmaceutical logistics and air cargo ecosystem.
Webinar Details
11 March, 14:00 CET
Online, on Microsoft Teams